Education
About Us
Working with TipRanks
Follow Us
Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -3.57M | $ -5.09M | $ -6.31M | $ -6.72M | $ -3.27M |
| EBITDA | $ -3.57M | $ -5.07M | $ -6.30M | $ -6.72M | $ 0.00 |
| Net Income | $ -3.59M | $ -5.09M | $ -6.31M | $ -6.73M | $ -3.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.04M | $ 4.20M | $ 5.35M | $ 4.82M | $ 5.07M |
| Total Assets | $ 1.15M | $ 4.31M | $ 5.56M | $ 5.09M | $ 5.23M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -1.04M | $ -4.20M | $ -5.35M | $ -4.82M | $ -5.07M |
| Total Liabilities | $ 318.28K | $ 313.86K | $ 395.76K | $ 302.93K | $ 216.52K |
| Stockholders' Equity | $ 827.22K | $ 3.99M | $ 5.17M | $ 4.79M | $ 5.01M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.16M | $ -4.29M | $ -4.61M | $ -4.14M | $ -2.13M |
| Operating Cash Flow | $ -3.16M | $ -4.29M | $ -4.61M | $ -4.14M | $ -2.13M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 3.14M | $ 5.14M | $ 3.90M | $ 4.60M |
Lixte Biotechnology Holdings Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.